ADCY10 and ischemic stroke: Currently, it has been reported that SAC has some pharmacological properties related to cerebral ischemia, including anti-inflammation, anti-oxidation, anti-platelet aggregation, and anti-apoptosis mechanisms (Song et al., 2018; Duan et al., 2019; He et al., 2019), but the functional mechanisms of SAC in the treatment of ischemic stroke is still unknown.